Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

MECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Incidence, prevalence and risk factors for hepatitis C in Danish prisons

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The Strengths and Difficulties Questionnaire and standardized academic tests: Reliability across respondent type and age

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The clinical, biochemical and genetic features associated with RMND1-related mitochondrial disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Exercise Intolerance and Myoglobinuria Associated with a Novel Maternally Inherited MT-ND1 Mutation

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Hearing impairment and renal failure associated with RMND1 mutations

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Cinzia Signorini
  • Claudio De Felice
  • Silvia Leoncini
  • Rikke S Møller
  • Gloria Zollo
  • Sabrina Buoni
  • Alessio Cortelazzo
  • Roberto Guerranti
  • Thierry Durand
  • Lucia Ciccoli
  • Maurizio D'Esposito
  • Kirstine Ravn
  • Joussef Hayek
View graph of relations

Rett syndrome (RTT) and MECP2 duplication syndrome (MDS) are neurodevelopmental disorders caused by alterations in the methyl-CpG binding protein 2 (MECP2) gene expression. A relationship between MECP2 loss-of-function mutations and oxidative stress has been previously documented in RTT patients and murine models. To date, no data on oxidative stress have been reported for the MECP2 gain-of-function mutations in patients with MDS. In the present work, the pro-oxidant status and oxidative fatty acid damage in MDS was investigated (subjects n = 6) and compared to RTT (subjects n = 24) and healthy condition (subjects n = 12). Patients with MECP2 gain-of-function mutations showed increased oxidative stress marker levels (plasma non-protein bound iron, intraerythrocyte non-protein bound iron, F2-isoprostanes, and F4-neuroprostanes), as compared to healthy controls (P ≤ 0.05). Such increases were similar to those observed in RTT patients except for higher plasma F2-isoprostanes levels (P < 0.0196). Moreover, plasma levels of F2-isoprostanes were significantly correlated (P = 0.0098) with the size of the amplified region. The present work shows unique data in patients affected by MDS. For the first time MECP2 gain-of-function mutations are indicated to be linked to an oxidative damage and related clinical symptoms overlapping with those of MECP2 loss-of-function mutations. A finely tuned balance of MECP2 expression appears to be critical to oxidative stress homeostasis, thus shedding light on the relevance of the redox balance in the central nervous system integrity.

Original languageEnglish
JournalP L o S One
Volume11
Issue number3
Pages (from-to)e0150101
ISSN1932-6203
DOIs
Publication statusPublished - 2016

    Research areas

  • Adolescent, Child, Child, Preschool, F2-Isoprostanes, Fatty Acids, Female, Humans, Male, Mental Retardation, X-Linked, Methyl-CpG-Binding Protein 2, Mutation, Oxidative Stress, Reactive Oxygen Species, Rett Syndrome, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't

ID: 49237455